Stem Cell Legislation & Policy
Key laws and policies that shaped funding, ethics, and research practice.
Stem Cell Therapeutic and Research Reauthorization Act of 2025 (H.R. 5160)
Reauthorizes and updates the Stem Cell Therapeutic and Research Act of 2005. The bill passed the House by voice vote on July 20, 2026, and was sent to the Senate.
NIH Ends Funding for Research Using Human Fetal Tissue
The National Institutes of Health announced that, effective immediately, NIH funds would no longer support research involving human fetal tissue from elective abortions.
California Proposition 14: Stem Cell Research Institute Bond Initiative
California voters approved Proposition 14 with 51.1% of the vote, authorizing $5.5 billion in general obligation bonds for the California Institute for Regenerative Medicine (CIRM).
United States v. US Stem Cell Clinic
A federal court in Florida ruled that the stromal vascular fraction cell product made by US Stem Cell Clinic from patients’ fat was a drug subject to FDA regulation, and granted the FDA a permanent injunction.
Right to Try Act (S. 204)
President Donald Trump signed the Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act, Public Law 115-176.
FDA Regenerative Medicine Policy Framework
The FDA announced a policy framework for regenerative medicine products, including final guidance on when human cells and tissues are minimally manipulated and intended for homologous use.
21st Century Cures Act (Public Law 114-255)
President Barack Obama signed the 21st Century Cures Act. Section 3033 created the Regenerative Medicine Advanced Therapy (RMAT) designation.
Stem Cell Therapeutic and Research Reauthorization Act of 2015 (H.R. 2820)
Became Public Law 114-104, reauthorizing the Stem Cell Therapeutic and Research Act of 2005.
Japan’s Act on the Safety of Regenerative Medicine and PMD Act Take Effect
Japan’s Act on the Safety of Regenerative Medicine and the revised Pharmaceuticals and Medical Devices (PMD) Act took effect.
Brüstle v Greenpeace (Case C-34/10)
The Court of Justice of the European Union ruled that an invention cannot be patented in the EU if it requires the prior destruction of human embryos or their use as base material.
Sherley v. Sebelius
A federal district judge issued a preliminary injunction blocking NIH funding of human embryonic stem cell research under its 2009 guidelines, finding it likely violated the Dickey-Wicker Amendment.
NIH Guidelines for Human Stem Cell Research
The National Institutes of Health published final guidelines, effective the same day, implementing Executive Order 13505.
Executive Order 13505: Removing Barriers to Responsible Scientific Research Involving Human Stem Cells
The purpose of this order by President Barack Obama was to remove "limitations on scientific inquiry, to expand NIH support for the exploration of human stem cell research, and in so doing to enhance the contribution of America's scientists to important new discoveries and new therapies for the benefit of humankind."
UK Human Fertilisation and Embryology Act 2008
The UK Human Fertilisation and Embryology Act 2008 received Royal Assent, updating the 1990 Act.
Michigan Proposal 2
Michigan voters approved Proposal 2 by 52.6% to 47.4%, amending the state constitution to allow embryonic stem cell research permitted under federal law.
EU Regulation on Advanced Therapy Medicinal Products (No 1394/2007)
The European Parliament and Council adopted Regulation (EC) No 1394/2007 on advanced therapy medicinal products, which applied from December 30, 2008.
Executive Order 13435: Expanding Approved Stem Cell Lines in Ethically Responsible Ways
On June 20, 2007, President George W. Bush vetoed the Stem Cell Research Enhancement Act of 2007 (S. 5). Alongside his veto, he issued an Executive Order promoting alternative, ethically responsible scientific methods—such as reprogramming adult skin cells—to create pluripotent stem cells without the destruction of human embryos.
Missouri Amendment 2: Stem Cell Research and Cures Initiative
Missouri voters approved Amendment 2 with 51.2% of the vote, amending the state constitution.
Stem Cell Research Enhancement Act (H.R. 810)
The Stem Cell Research Enhancement Act (H.R. 810) aimed to expand federal funding for human embryonic stem cell research by allowing the use of stem cells derived from embryos donated from in vitro fertilization clinics. It was vetoed by President George W. Bush on July 19, 2006, who argued it crossed a moral boundary by supporting the destruction of human embryos. The same day, the House failed, 235-193, to override President Bush’s veto, falling short of the two-thirds majority needed to override a presidential veto.
Stem Cell Therapeutic and Research Act of 2005 (Public Law 109-129)
President George W. Bush signed the Stem Cell Therapeutic and Research Act of 2005.
The California Stem Cell Research and Cures Act (Proposition 71)
The Act makes conducting stem cell research a state constitutional right. It authorizes the sale of general obligation bonds to allocate three billion dollars over a period of ten years to stem cell research and research facilities. Although the funds could be used to finance all kinds of stem cell research, it gives priority to human embryonic stem cell research.
New Jersey Stem Cell Research Law
New Jersey Governor James McGreevey signed a law (P.L. 2003, c. 203) permitting research on human embryonic, germ and adult stem cells.
President Bush Limits Federal Funding of Embryonic Stem Cell Research
President George W. Bush announced that federal funds could be used only for research on human embryonic stem cell lines that already existed as of August 9, 2001.
UK Human Fertilisation and Embryology (Research Purposes) Regulations 2001
New UK regulations came into force allowing licensed embryo research for additional purposes.
The Dickey-Wicker Amendment
Congress bans the federal funding for research on embryos through the Dickey-Wicker Amendment, named after its sponsors Jay Dickey (R-AR) and Roger Wicker (R-MS). It was first enacted in the Balanced Budget Downpayment Act, I (Public Law 104-99), signed on January 26, 1996.
UK Human Fertilisation and Embryology Act 1990
The UK Human Fertilisation and Embryology Act 1990 received Royal Assent.
